Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 5851035, 14 pages
http://dx.doi.org/10.1155/2016/5851035
Review Article

Oxidative Stress and Mitochondrial Activation as the Main Mechanisms Underlying Graphene Toxicity against Human Cancer Cells

Department of General & Experimental Pathology and Centre for Preclinical Research and Technology (CEPT), Medical University of Warsaw, Pawińskiego 3C, 02-106 Warsaw, Poland

Received 22 April 2015; Revised 10 June 2015; Accepted 21 July 2015

Academic Editor: Sahdeo Prasad

Copyright © 2016 Anna Jarosz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. S. Novoselov, A. K. Geim, S. V. Morozov et al., “Electric field in atomically thin carbon films,” Science, vol. 306, no. 5696, pp. 666–669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. E.-J. Park, G.-H. Lee, B. S. Han et al., “Toxic response of graphene nanoplatelets in vivo and in vitro,” Archives of Toxicology, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M.-G. Kim, J. Y. Park, Y. Shon, G. Shim, and Y.-K. Oh, “Pharmaceutical applications of graphene-based nanosheets,” Current Pharmaceutical Biotechnology, vol. 14, no. 12, pp. 1016–1026, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Chatterjee, H.-J. Eom, and J. Choi, “A systems toxicology approach to the surface functionality control of graphene-cell interactions,” Biomaterials, vol. 35, no. 4, pp. 1109–1127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Gurunathan, J. W. Han, J. H. Park, and J. H. Kim, “An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231),” International Journal of Nanomedicine, vol. 9, no. 1, pp. 1783–1797, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Yuan, Z. Liu, Z. Guo, Y. Ji, M. Jin, and X. Wang, “Cellular distribution and cytotoxicity of graphene quantum dots with different functional groups,” Nanoscale Research Letters, vol. 9, no. 1, pp. 1–9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D.-J. Lim, M. Sim, L. Oh, K. Lim, and H. Park, “Carbon-based drug delivery carriers for cancer therapy,” Archives of Pharmacal Research, vol. 37, no. 1, pp. 43–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-G. Oh, H.-G. Nam, D.-H. Kim, M.-H. Kim, K.-H. Jhee, and K. S. Song, “Neuroblastoma cells grown on fluorine or oxygen treated graphene sheets,” Materials Letters, vol. 131, pp. 328–331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Wang, Z. Li, J. Wang, J. Li, and Y. Lin, “Graphene and graphene oxide: biofunctionalization and applications in biotechnology,” Trends in Biotechnology, vol. 29, no. 5, pp. 205–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Jaworski, E. Sawosz, M. Grodzik et al., “In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells,” International Journal of Nanomedicine, vol. 8, pp. 413–420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Guo and N. Mei, “Assessment of the toxic potential of graphene family nanomaterials,” Journal of Food and Drug Analysis, vol. 22, no. 1, pp. 105–115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Shen, L. Zhang, M. Liu, and Z. Zhang, “Biomedical applications of graphene,” Theranostics, vol. 2, no. 3, pp. 283–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Liu, Y. Luo, J. Wu et al., “Graphene oxide can induce in vitro and in vivo mutagenesis,” Scientific Reports, vol. 3, article 3469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Jaworski, E. Sawosz, M. Kutwin et al., “In vitro and in vivo effects of graphene oxide and reduced graphene oxide on glioblastoma,” International Journal of Nanomedicine, vol. 10, pp. 1585–1596, 2015. View at Google Scholar
  15. H. Y. Mao, S. Laurent, W. Chen et al., “Graphene: promises, facts, opportunities, and challenges in nanomedicine,” Chemical Reviews, vol. 113, no. 5, pp. 3407–3424, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Chong, Y. Ma, H. Shen et al., “The in vitro and in vivo toxicity of graphene quantum dots,” Biomaterials, vol. 35, no. 19, pp. 5041–5048, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. T. L. Moore, R. Podilakrishna, A. Rao, and F. Alexis, “Systemic administration of polymer-coated nano-graphene to deliver drugs to glioblastoma,” Particle and Particle Systems Characterization, vol. 31, no. 8, pp. 886–894, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Lammel, P. Boisseaux, M.-L. Fernández-Cruz, and J. M. Navas, “Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2,” Particle and Fibre Toxicology, vol. 10, article 27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. B. Seabra, A. J. Paula, R. De Lima, O. L. Alves, and N. Durán, “Nanotoxicity of graphene and graphene oxide,” Chemical Research in Toxicology, vol. 27, no. 2, pp. 159–168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Talukdar, J. T. Rashkow, G. Lalwani, S. Kanakia, and B. Sitharaman, “The effects of graphene nanostructures on mesenchymal stem cells,” Biomaterials, vol. 35, no. 18, pp. 4863–4877, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Skoda, I. Dudek, A. Jarosz, and D. Szukiewicz, “Graphene: one material, many possibilities—application difficulties in biological systems,” Journal of Nanomaterials, vol. 2014, Article ID 890246, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L. de Marzi, L. Ottaviano, F. Perrozzi et al., “Flake size-dependent cyto and genotoxic evaluation of graphene oxide on in vitro A549, CaCo2 and vero cell lines,” Journal of Biological Regulators & Homeostatic Agents, vol. 28, no. 2, pp. 281–289, 2014. View at Google Scholar · View at Scopus
  23. H. Wang, W. Gu, N. Xiao, L. Ye, and Q. Xu, “Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 1433–1442, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. E. L. K. Chng, Z. Sofer, and M. Pumera, “Cytotoxicity profile of highly hydrogenated graphene,” Chemistry A European Journal, vol. 20, no. 21, pp. 6366–6373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Sun, Z. Liu, K. Welsher et al., “Nano-graphene oxide for cellular imaging and drug delivery,” Nano Research, vol. 1, no. 3, pp. 203–212, 2008. View at Publisher · View at Google Scholar
  26. A. Wang, K. Pu, B. Dong et al., “Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells,” Journal of Applied Toxicology, vol. 33, no. 10, pp. 1156–1164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Zhou, X. Zhou, and D. Xing, “Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier,” Biomaterials, vol. 35, no. 13, pp. 4185–4194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Bera, M. Ghosh, M. Pal et al., “Synthesis, characterization and cytotoxicity of europium incorporated ZnO-graphene nanocomposites on human MCF7 breast cancer cells,” RSC Advances, vol. 4, no. 71, pp. 37479–37490, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Shim, J.-Y. Kim, J. Han et al., “Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs,” Journal of Controlled Release, vol. 189, pp. 80–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Mullick Chowdhury, G. Lalwani, K. Zhang, J. Y. Yang, K. Neville, and B. Sitharaman, “Cell specific cytotoxicity and uptake of graphene nanoribbons,” Biomaterials, vol. 34, no. 1, pp. 283–293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Gurunathan, J. W. Han, V. Eppakayala, and J.-H. Kim, “Green synthesis of graphene and its cytotoxic effects in human breast cancer cells,” International Journal of Nanomedicine, vol. 8, pp. 1015–1027, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. N. S. Chaudhari, A. P. Pandey, P. O. Patil, A. R. Tekade, S. B. Bari, and P. K. Deshmukh, “Graphene oxide based magnetic nanocomposites for efficient treatment of breast cancer,” Materials Science and Engineering C, vol. 37, no. 1, pp. 278–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Zhang, W. Hu, J. Li, L. Tao, and Y. Wei, “A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond,” Toxicology Research, vol. 1, no. 1, pp. 62–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. O. J. Yoon, I. Kim, I. Y. Sohn, T. T. Kieu, and N.-E. Lee, “Toxicity of graphene nanoflakes evaluated by cell-based electrochemical impedance biosensing,” Journal of Biomedical Materials Research—Part A, vol. 102, no. 7, pp. 2288–2294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Chang, S.-T. Yanga, J.-H. Liua et al., “In vitro toxicity evaluation of graphene oxide on A549 cells,” Toxicology Letters, vol. 200, no. 3, pp. 201–210, 2011. View at Publisher · View at Google Scholar
  36. W. Hu, C. Peng, M. Lv et al., “Protein corona-mediated mitigation of cytotoxicity of graphene oxide,” ACS Nano, vol. 5, no. 5, pp. 3693–3700, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Hu, C. Peng, W. Luo et al., “Graphene-based antibacterial paper,” ACS Nano, vol. 4, no. 7, pp. 4317–4323, 2010. View at Google Scholar
  38. S. Wu, X. Zhao, Z. Cui et al., “Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 1413–1421, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Wang, S. Ravi, U. S. Garapati et al., “Multifunctional chitosan magnetic-graphene (CMG) nanoparticles: a theranostic platform for tumor-targeted co-delivery of drugs, genes and MRI contrast agents,” Journal of Materials Chemistry B, vol. 1, no. 35, pp. 4396–4405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Jin, F. Wang, Y. Tang, X. Zhang, J. Wang, and Y. Yang, “Distribution of graphene oxide and TiO2-graphene oxide composite in A549 cells,” Biological Trace Element Research, vol. 159, no. 1–3, pp. 393–398, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. Liu, J. T. Robinson, S. M. Tabakman, K. Yang, and H. Dai, “Carbon materials for drug delivery & cancer therapy,” Materials Today, vol. 14, no. 7-8, pp. 316–323, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. U. Waiwijit, W. Kandhavivorn, B. Oonkhanond et al., “Cytotoxicity assessment of MDA-MB-231 breast cancer cells on screen-printed graphene-carbon paste substrate,” Colloids and Surfaces B: Biointerfaces, vol. 113, pp. 190–197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Liu, Y. Zhang, T. Zhang, Y. Jiang, and X. Liu, “Synthesis, characterization and cytotoxicity of phosphorylcholine oligomer grafted graphene oxide,” Carbon, vol. 71, pp. 166–175, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Gurunathan, J. W. Han, V. Eppakayala, and J.-H. Kim, “Microbial reduction of graphene oxide by Escherichia coli: a green chemistry approach,” Colloids and Surfaces B: Biointerfaces, vol. 102, pp. 772–777, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Yuan, H. Gao, and C. B. Ching, “Comparative protein profile of human hepatoma HepG2 cells treated with graphene and single-walled carbon nanotubes: an iTRAQ-coupled 2D LC-MS/MS proteome analysis,” Toxicology Letters, vol. 207, no. 3, pp. 213–221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Hinzmann, S. Jaworski, M. Kutwin et al., “Nanoparticles containing allotropes of carbon have genotoxic effects on glioblastoma multiforme cells,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 2409–2417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Zhou, B. Zhang, P. Wei et al., “Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets,” Biomaterials, vol. 35, no. 37, pp. 9833–9843, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Zhou, B. Zhang, J. Zheng et al., “The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration,” Biomaterials, vol. 35, no. 5, pp. 1597–1607, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Romero-Aburto, T. N. Narayanan, Y. Nagaoka et al., “Fluorinated graphene oxide; a new multimodal material for biological applications,” Advanced Materials, vol. 25, no. 39, pp. 5632–5637, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Zhang, K. Yang, L. Feng, and Z. Liu, “In vitro and in vivo behaviors of dextran functionalized graphene,” Carbon, vol. 49, no. 12, pp. 4040–4049, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Yuan, H. Gao, J. Sui, H. Duan, W. N. Chen, and C. B. Ching, “Cytotoxicity evaluation of oxidized single-walled carbon nanotubes and graphene oxide on human hepatoma HepG2 cells: an iTRAQ-coupled 2D LC-MS/MS proteome analysis,” Toxicological Sciences, vol. 126, no. 1, pp. 149–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. J. T. Robinson, S. M. Tabakman, Y. Liang et al., “Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy,” Journal of the American Chemical Society, vol. 133, no. 17, pp. 6825–6831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. O. N. Ruiz, K. A. S. Fernando, B. Wang et al., “Graphene oxide: a nonspecific enhancer of cellular growth,” ACS Nano, vol. 5, no. 10, pp. 8100–8107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. R. Burke, R. N. Singh, D. L. Carroll, F. M. Torti, and S. V. Torti, “Targeting cancer stem cells with nanoparticle-enabled therapies,” Journal of Molecular Biomarkers & Diagnosis, vol. 8, pp. 1–8, 2012. View at Google Scholar
  55. M. Fiorillo, A. F. Verre, M. Iliut et al., “Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via ‘differentiation-based nano-therapy’,” Oncotarget, vol. 6, no. 6, pp. 3553–3562, 2015. View at Google Scholar
  56. A. M. Pinto, I. C. Gonçalves, and F. D. Magalhães, “Graphene-based materials biocompatibility: a review,” Colloids and Surfaces B: Biointerfaces, vol. 111, pp. 188–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Miao, G. Shim, C. M. Kang et al., “Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery,” Biomaterials, vol. 34, no. 37, pp. 9638–9647, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Jiang, W. Sun, Q. Zhu et al., “Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene,” Advanced Materials, vol. 27, no. 6, pp. 1021–1028, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. S.-E. Jin, H.-E. Jin, and S.-S. Hong, “Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics,” BioMed Research International, vol. 2014, Article ID 814208, 23 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. X. Zhao, L. Yang, X. Li et al., “Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug,” Bioconjugate Chemistry, vol. 26, no. 1, pp. 128–136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. Z. Xu, S. Zhu, M. Wang, Y. Li, P. Shi, and X. Huang, “Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier,” ACS Applied Materials and Interfaces, vol. 7, no. 2, pp. 1355–1363, 2015. View at Publisher · View at Google Scholar · View at Scopus